UNSPSC 85819301: Transfusion of autologous antihemophilic factors into peripheral vein, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to transfusion of autologous antihemophilic factors into peripheral vein, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 30233V0

UNSPSC 85819301 Transfusion of autologous antihemophilic factors into peripheral vein, percutaneous approach, a Commodity code, does not align with the state and local contract opportunities recently posted under this classification. The recent solicitations posted under the code span independent medical evaluation services for public safety pension disability determinations, surgical and medical procedure carve-out benefit programs, occupational medical surveillance, specialty healthcare services for detained youth, pharmacy benefit management, and temporary health professional staffing—none of which involve transfusion therapy or autologous factor administration. The mismatch suggests either systematic miscoding at the source or that this UNSPSC designation sees limited state and local procurement activity in its actual clinical scope.

The issuing bodies in the recent activity include city retirement offices (Phoenix), municipalities (Long Beach), state transportation departments (Washington), county health systems (Santa Clara), county probation departments (Harris County), and county commissioners offices (Collier County). Geographic spread includes Arizona, California, Washington, and Florida, with no clear concentration in any single state. Given the disconnect between the code's clinical definition and the actual work being procured, firms pursuing this commodity should verify code accuracy during pre-bid review or Q&A cycles rather than rely on the current classification to surface relevant opportunities.